C.M. Bidwell & Associates’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,180
| Closed | -$63.7K | – | 463 |
|
|
2025
Q1 | $63.7K | Buy |
3,180
+482
| +18% | +$9.65K | 0.04% | 200 |
|
|
2024
Q4 | $71.9K | Buy |
2,698
+98
| +4% | +$2.61K | 0.04% | 204 |
|
|
2024
Q3 | $74.2K | Buy |
2,600
+945
| +57% | +$27K | 0.05% | 200 |
|
|
2024
Q2 | $36K | Buy |
+1,655
| New | +$36K | 0.02% | 245 |
|
|
2023
Q2 | – | Sell |
-75
| Closed | -$1.7K | – | 534 |
|
|
2023
Q1 | $1.7K | Buy |
+75
| New | +$1.7K | ﹤0.01% | 482 |
|
|
2021
Q2 | – | Sell |
-265
| Closed | -$18K | – | 578 |
|
|
2021
Q1 | $18K | Sell |
265
-70
| -21% | -$4.76K | 0.01% | 356 |
|
|
2020
Q4 | $22K | Sell |
335
-7,000
| -95% | -$460K | 0.02% | 332 |
|
|
2020
Q3 | $377K | Sell |
7,335
-230
| -3% | -$11.8K | 0.35% | 41 |
|
|
2020
Q2 | $285K | Sell |
7,565
-1,270
| -14% | -$47.8K | 0.26% | 85 |
|
|
2020
Q1 | $263K | Buy |
8,835
+6,685
| +311% | +$199K | 0.28% | 95 |
|
|
2019
Q4 | $74K | Buy |
+2,150
| New | +$74K | 0.07% | 179 |
|